1. Stocks
    2. /
  2. CSL (ASX: CSL)
    3. /

CSL (ASX: CSL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CSL Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • CSL (ASX: CSL)
    Latest News

    A fresh-faced young woman holds an Australian flag aloft above her head as she smiles widely.
    Cheap Shares

    Buy Australian: ASX stocks positioned to beat global markets next year

    | James Mickleboro

    Let's see why these shares could be destined to outperform in 2026 according to analysts.

    Read more »

    Five people are lunging for the finish line on an athletics track with the picture taken from above as an aerial view of the athletes with their arms outstretched.
    Opinions

    5 ASX 200 shares I'd buy with $10,000 this week

    | Samantha Menzies

    I like the look of these ASX 200 shares.

    Read more »

    man in old fashioned suit and hat looking through magnifying glass
    Blue Chip Shares

    Is the CSL share price a generational bargain at $180?

    | Aaron Teboneras

    CSL shares are currently trading near a 7-year low.

    Read more »

    Buy now written on a red key with a shopping trolley on an Apple keyboard.
    Share Market News

    10 most-traded ASX shares last week

    | Samantha Menzies

    Some new companies joined the top-10 list for the first week of December.

    Read more »

    Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
    Healthcare Shares

    Own CSL shares? Here are the key dates for 2026

    | Bronwyn Allen

    It's been a bad year for CSL shares. What's ahead in 2026?

    Read more »

    A male doctor wearing a white doctor's coat shrugs and holds his hands up to indicate the unimpressive CSL share price as a result of OOVID-19
    Healthcare Shares

    Here's the earnings forecast out to 2030 for CSL shares

    | Tristan Harrison

    How healthy will the profit growth be in the coming years?

    Read more »

    man with dog on his lap looking at his phone in his home.
    Broker Notes

    Top brokers name 3 ASX shares to buy next week

    | James Mickleboro

    Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

    Read more »

    Ecstatic woman looking at her phone outside with her fist pumped.
    Growth Shares

    Here are the 3 Australian stocks I'd tell a new investor to buy asap

    | James Mickleboro

    These shares could be top picks for new investors right now. Let's dig deeper into them.

    Read more »

    A financial expert or broker looks worried as he checks out a graph showing market volatility.
    Blue Chip Shares

    2 big ASX 200 shares this fund manager rates as buys

    | Tristan Harrison

    These large businesses could be strong contenders for returns.

    Read more »

    Broker written in white with a man drawing a yellow underline.
    Broker Notes

    Brokers name 3 ASX shares to buy today

    | James Mickleboro

    Here's why brokers are feeling bullish about these three shares this week.

    Read more »

    Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
    Healthcare Shares

    Why CSL shares now look 'massively oversold'

    | Bernd Struben

    A leading investment expert says ASX investors have a rare chance to buy CSL shares at a discount.

    Read more »

    A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
    Opinions

    4 ASX shares I'd buy today with $10,000

    | Samantha Menzies

    I think these shares are set to soar.

    Read more »

    Frequently Asked Questions

    CSL was listed on the ASX in June 1994.

    CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.

    Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.

    CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.

    CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents. 

    CSL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About CSL

    CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.

    CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.

    CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).

    The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.

     

    Profile

    since

    Note